--- title: "Does Testosterone Cause Prostate Cancer? | ReGenesis" description: "Evidence-based guide to testosterone therapy and prostate cancer risk — TRAVERSE trial, saturation model, and current AUA & Endocrine Society guidance." lang: en json-ld: | { "@context": "https://schema.org", "@type": "MedicalWebPage", "name": "Does Testosterone Cause Prostate Cancer? | Evidence-Based Guide", "description": "Evidence-based guide on testosterone therapy and prostate cancer risk. Review of TRAVERSE trial, saturation model, and clinical guidelines from the Endocrine Society and AUA.", "url": "https://regenesislongevity.com/testosterone-prostate-cancer", "about": { "@type": "MedicalCondition", "name": "Prostate Cancer", "riskFactor": { "@type": "MedicalRiskFactor", "name": "Testosterone Replacement Therapy (investigated — no causal link established)" } }, "mainEntity": { "@type": "Question", "name": "Does testosterone cause prostate cancer?", "acceptedAnswer": { "@type": "Answer", "text": "Current evidence, including the TRAVERSE trial and multiple meta-analyses, does not support a causal link between testosterone replacement therapy and prostate cancer. The Endocrine Society, AUA, and EAU guidelines confirm TRT is appropriate for men with hypogonadism who do not have active prostate cancer." } }, "provider": { "@type": "MedicalClinic", "name": "ReGenesis Longevity Clinic™", "telephone": "+15876353414", "email": "contact@regenesislongevity.com", "address": [ { "@type": "PostalAddress", "streetAddress": "213, 5540 Windermere Blvd", "addressLocality": "Edmonton", "addressRegion": "AB", "postalCode": "T6W 2Z8", "addressCountry": "CA" }, { "@type": "PostalAddress", "streetAddress": "1102, 8561 8A Ave SW", "addressLocality": "Calgary", "addressRegion": "AB", "postalCode": "T3H 0V5", "addressCountry": "CA" } ] } } --- [![ReGenesis Longevity Clinic logo — Edmonton and Calgary preventive health and hormone therapy](/assets/logo-blue-WRupJqE0.png)](/) [Home](/)[Process](/#process)[About](/#about) Resources [Blog](/blog)[FAQ](/faq)[Contact](/contact) [Book Consultation](/contact) Evidence-Based Clinical Guide # Does Testosterone Cause Prostate Cancer? For decades, men have been told that testosterone therapy increases prostate cancer risk. This belief is based on a misinterpretation of 80-year-old research. Here's what the current evidence — including the landmark TRAVERSE trial — actually shows. [Discuss Your Risk Profile](/contact)[587.635.3414](tel:+15876353414) 5,246 Men in TRAVERSE Trial No Link TRT → Prostate Cancer ## Testosterone & Prostate Cancer: Myths vs. Evidence Separating decades of fear from what peer-reviewed research actually demonstrates about testosterone and prostate cancer risk. Myth Testosterone causes prostate cancer Evidence No large-scale, well-designed study has demonstrated a causal link between testosterone replacement therapy and prostate cancer. The Endocrine Society, AUA, and EAU guidelines all confirm that TRT does not increase prostate cancer risk in men without active disease. Myth Higher testosterone levels mean higher prostate cancer risk Evidence The 'saturation model' (Morgentaler, 2006) demonstrates that prostate tissue becomes saturated at relatively low testosterone levels (~250 ng/dL). Above this threshold, additional testosterone does not further stimulate prostate growth. Myth Men who had prostate cancer can never use TRT Evidence Emerging evidence supports cautious use of TRT in select men after successful prostate cancer treatment. Multiple studies show no increased recurrence in men on TRT post-radical prostatectomy, though this requires close clinical supervision. Myth TRT raises PSA dangerously Evidence TRT may cause a modest initial PSA rise (typically 0.3–0.5 ng/mL), which stabilizes within 6–12 months. This is monitored routinely and does not indicate cancer development. Persistent or rapid PSA elevation warrants investigation regardless of TRT status. ## How the Science Evolved The fear of testosterone causing prostate cancer originated from a misinterpretation in 1941. Here's how 80 years of research corrected the record. ### The Huggins Misunderstanding (1941) Dr. Charles Huggins won a Nobel Prize for showing that castration (removing testosterone) could shrink advanced prostate cancer. This was incorrectly extrapolated to mean that testosterone causes prostate cancer — a logical fallacy that persisted for decades. ### The Saturation Model (2006) Dr. Abraham Morgentaler demonstrated that prostate tissue has a finite number of androgen receptors. Once saturated at low-normal testosterone levels (~250 ng/dL), additional testosterone cannot further stimulate prostate growth — debunking the dose-response myth. ### The TRAVERSE Trial (2023) The largest randomized TRT trial (5,246 men, 33-month median follow-up) found no statistically significant increase in prostate cancer incidence in men receiving testosterone versus placebo. ### Meta-Analyses & Systematic Reviews Multiple meta-analyses (including Boyle et al., 2016 and Corona et al., 2017) reviewing thousands of patients on TRT consistently show no increased risk of prostate cancer compared to untreated controls. ## The Low Testosterone Paradox Counterintuitively, research suggests that **low testosterone is associated with more aggressive, higher-grade prostate cancers**. Multiple studies have found that men diagnosed with prostate cancer who have low serum testosterone tend to have higher Gleason scores and worse outcomes. A 2016 meta-analysis published in _Medicine_ found that men with lower pre-treatment testosterone levels had significantly higher rates of aggressive prostate cancer compared to those with normal levels. This doesn't mean low testosterone causes prostate cancer — but it challenges the outdated assumption that higher testosterone is the driver. The relationship is far more nuanced than "more testosterone = more cancer." ## How We Monitor Prostate Safety During TRT While the evidence is reassuring, responsible TRT always includes prostate monitoring. Here's our protocol. ### Baseline PSA & Prostate Assessment Every patient receives a baseline PSA test, digital rectal exam referral when indicated, and complete hormonal panel before initiating therapy. ### Ongoing PSA Monitoring PSA is tested at 3 months, 6 months, 12 months, and annually thereafter. Any rise exceeding 1.4 ng/mL from baseline or a PSA velocity >0.75 ng/mL/year triggers further investigation. ### Expert Risk Stratification Our clinical team evaluates family history, ethnicity, age, and baseline PSA to stratify prostate cancer risk before and during treatment — ensuring every patient receives individualized monitoring. ### Evidence-Based Decision Framework All protocols align with the Endocrine Society, AUA, and EAU clinical guidelines. We use shared decision-making so patients understand the evidence and feel confident in their treatment plan. ## Key Takeaways What every man considering testosterone therapy should know about prostate cancer risk. No causal link between TRT and prostate cancer in current evidence The saturation model explains why higher testosterone doesn't increase risk TRAVERSE trial (5,246 men) found no increased prostate cancer incidence Low testosterone itself is associated with more aggressive prostate cancers PSA monitoring during TRT is standard and straightforward Post-prostatectomy TRT is increasingly supported in select patients Baseline screening and ongoing monitoring are essential for safety The Endocrine Society, AUA, and EAU all support TRT in appropriate candidates ### Edmonton — Windermere Windermere Plaza 213, 5540 Windermere Blvd, Edmonton, AB T6W 2Z8 [587.635.3414 ](tel:+15876353414) ### Calgary — Silk Touch Silk Touch 1102, 8561 8A Ave SW, Calgary, AB T3H 0V5 [403.454.8196 ](tel:+14034548196) [contact@regenesislongevity.com](mailto:contact@regenesislongevity.com) ## Get the Facts. Make an Informed Decision. Don't let outdated myths prevent you from treatment that could transform your health. Book a consultation to discuss your individual risk profile with our expert team who understand the evidence. [Book a Consultation](/contact)[Call 587.635.3414](tel:+15876353414) [![ReGenesis Longevity Clinic footer logo — longevity medicine in Edmonton and Calgary, Alberta](/assets/logo-footer-S7t4U9jL.png)](/) Pioneering precision medicine for extended healthspan. Live longer, live better. [](https://www.facebook.com/REGENESISAB/)[](https://www.instagram.com/regenesisab/)[](https://www.youtube.com/@lloydtapper9122) © 2026 ReGenesis Longevity Clinic™. All rights reserved. ### Programs - [Longevity Clinic Edmonton](/longevity-clinic-edmonton) - [Longevity Clinic Calgary](/longevity-clinic-calgary) - [Testosterone Therapy Edmonton](/testosterone-therapy-edmonton) - [Testosterone Therapy Calgary](/testosterone-therapy-calgary) - [Hormone Replacement Edmonton](/hormone-replacement-therapy-edmonton) - [Hormone Replacement Calgary](/hormone-replacement-therapy-calgary) - [Executive Health Program](/executive-health-optimization) - [Men's Health Assessment](/mens-health-assessment) ### Treatments - [Regenerative Medicine Edmonton](/regenerative-medicine-edmonton) - [Regenerative Medicine Calgary](/regenerative-medicine-calgary) - [Weight Loss (GLP-1) Edmonton](/weight-loss-glp1-edmonton) - [Weight Loss (GLP-1) Calgary](/weight-loss-glp1-calgary) - [Hydro-Dilation Edmonton](/hydro-dilation-frozen-shoulder-edmonton) - [Hydro-Dilation Calgary](/hydro-dilation-frozen-shoulder-calgary) - [Hydrodissection Edmonton](/hydrodissection-carpal-tunnel-edmonton) - [Hydrodissection Calgary](/hydrodissection-carpal-tunnel-calgary) - [ED Treatment Edmonton](/erectile-dysfunction-treatment-edmonton) - [ED Treatment Calgary](/erectile-dysfunction-treatment-calgary) - [Destination Surgery Edmonton](/destination-surgery-edmonton) - [Destination Surgery Calgary](/destination-surgery-calgary) ### Men's Health - [Men's Vascular Health](/mens-vascular-health) - [ED Evaluation](/erectile-dysfunction-evaluation) - [ED & Heart Disease](/erectile-dysfunction-heart-disease) - [TRT Safety](/testosterone-therapy-safety) - [Testosterone & Prostate Cancer](/testosterone-prostate-cancer) ### Company - [About Us](#about) - [Our Process](#process) - [Locations](/#locations) ### Resources - [Blog](/blog) - [FAQ](/faq) ### Featured Articles - [PRP for Joints, Tendons & Ligaments](/blog/platelet-rich-plasma-joint-tendon-ligament-injuries) - [Ultrasound-Guided Prolotherapy](/blog/ultrasound-guided-prolotherapy-back-pain-si-joint) - [ED Treatment Options Guide](/blog/erectile-dysfunction-treatment-options) - [Healthspan vs. Lifespan in Canada](/blog/healthspan-vs-lifespan-canadian-healthcare) - [Estradiol & FDA Hormone Therapy](/blog/estradiol-fda-guidelines-hormone-therapy-women) - [Understanding Biological Age](/blog/understanding-your-biological-age) - [Full Body MRI Screening](/blog/full-body-mri-preventive-screening) - [Liquid Biopsy & Cancer Detection](/blog/liquid-biopsy-detecting-cancer) - [Biomarker Optimization Science](/blog/science-behind-biomarker-optimization) - [Proactive Longevity Medicine](/blog/longevity-medicine-proactive-healthcare) - [Hormonal Imbalances & Healthspan](/blog/hormonal-imbalances-healthspan) ### Our Network - [ReGenesis Alberta](https://www.regenesisalberta.com) - [ReGenesis TriMix](https://www.regenesistrimix.com) - [ReGenesis TRT](https://www.regenesistrt.com) [Privacy Policy](/privacy-policy)[Terms of Service](/terms-of-service)[HPA Compliance](/hpa-compliance) Partnered with TruDiagnostic, Precision Epigenomics, Insight Medical Imaging, Alberta Precision Laboratories, Dispensaries Compounding Pharmacy Chat with Orin Online now